. 2021 Aug 9;6(33):21327–21338. doi: 10.1021/acsomega.1c01555
© 2021 The Authors. Published by American Chemical Society
Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1.
Reported sub-family VIII bromodomain inhibitors.